Table 5 Per patient and total annual direct medical cost and total annual indirect -cost related to management of lung cancer
From: Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
Direct cost | Per patient annual cost (€) | Contribution to per patient cost (%) | Total cost (€) | Contribution to total cost (%) | ||
SCLC | NSCLC | SCLC | NSCLC | |||
Number of patients | 7,500 | 42,500 | Â | Â | Â | Â |
Direct cost items | ||||||
 Outpatient admission | 338.94 | 489.56 | 3.8 | 4.8 | 41,328,467.61 | 8 |
 Laboratory test-imaging | 316.42 | 367.24 | 3.6 | 3.6 | a | a |
 Hospitalization/intervention | 4,116.98 | 4,028.75 | 46.9 | 39.6 | 202,099,412.37 | 41 |
 Drug treatment | 1,484.19 | 2,765.58 | 16.9 | 27.2 | 128,668,391.79 | 26 |
 Adverse events | 999.57 | 999.57 | 11.4 | 9.8 | 49,978,377.04 | 10 |
 Metastasis | 1,516.40 | 1,516.4 | 17.3 | 14.9 | 75,820,050.53 | 15 |
Total direct per patient cost | 8,772.49 | 10,167.07 | Â | Â | Â | |
TOTAL DIRECT COST(€) |  | 497,894,699.34 | ||||
Indirect cost | ||||||
Cost items | Number of persons | Total cost | ||||
Lost productivity (patient) | ||||||
Lost productivity due to premature death | 15,000 | 529,306,931 | ||||
Lost productivity due to time spent in hospital | 50,000 | 31,480,660 | ||||
Travel distance | 30,000 | 16,633,663 | ||||
Lost productivity due to disability retirement | 4,000 | 167,805,581 | ||||
Lost productivity due to medical reports | 25,000 | 162,769,322 | ||||
Lost productivity due to early retirement | 8,800 | 141,148,515 | ||||
Total | 50,000 | 1,049,144,671 | ||||
Lost productivity (family caregiver) | 47,500 | 29,906,627 | ||||
Formal caregiver cost | 2,500 | 5,751,575 | ||||
TOTAL INDIRECT COST (€) |  | 1,084,802,873.6 | ||||